Inventor

GINN JOHN DAVID

US10 patents

⚠️ This page may combine multiple inventors who share the name “GINN JOHN DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BOEHRINGER INGELHEIM INT

3 patents

US9353090B2May 31, 2016

Heterocyclic carboxylic acids as activators of soluble guanylate cyclase

BOEHRINGER INGELHEIM INT6 citations69

US8362249B2Jan 29, 2013

CXCR3 receptor antagonists

BOEHRINGER INGELHEIM INT1 citations51

US7592353B2Sep 22, 2009

Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses

BOEHRINGER INGELHEIM INT0 citations51

BOSANAC TODD

2 patents

US8809326B2Aug 19, 2014

Isoquinolinone Rho kinase inhibitors

BOSANAC TODD40 citations90

US8815857B2Aug 26, 2014

Soluble guanylate cyclase activators

BOSANAC TODD1 citations48

GINN JOHN DAVID

2 patents

US9079880B2Jul 14, 2015

Rho kinase inhibitors

GINN JOHN DAVID4 citations69

US8952004B2Feb 10, 2015

CXCR3 receptor antagonists

GINN JOHN DAVID2 citations59

BOEHRINGER INGELHEIM PHARMA

2 patents

US7329764B2Feb 12, 2008

Substitute benzothiophene compounds

BOEHRINGER INGELHEIM PHARMA2 citations60

US7550473B2Jun 23, 2009

Pyrimidine derivatives useful as inhibitors of PKC-theta

BOEHRINGER INGELHEIM PHARMA6 citations59

AERIE PHARMACEUTICALS INC

1 patent

US10624882B2Apr 21, 2020

Rho kinase inhibitors

AERIE PHARMACEUTICALS INC0 citations49